Hino, Japan

Yoshiaki Okamiya


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1986

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yoshiaki Okamiya: Innovator in Antihypertensive Compounds

Introduction

Yoshiaki Okamiya is a notable inventor based in Hino, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antihypertensive agents. His work has led to the creation of innovative compounds that have the potential to improve health outcomes for patients with hypertension.

Latest Patents

Yoshiaki Okamiya holds a patent for "Certain aralkylaminoalkyl esters of 1,4 dihydropyridines." This patent describes a 1,4-dihydropyridine derivative characterized by a strong antihypertensive activity and a long duration of effect. The compound is defined by a specific formula where various groups can represent different chemical entities, providing a versatile approach to treating hypertension.

Career Highlights

Okamiya is associated with Teijin Limited, a company known for its advancements in materials and pharmaceuticals. His work at Teijin has allowed him to focus on innovative research and development in the pharmaceutical sector. His contributions have been instrumental in advancing the understanding and treatment of hypertension.

Collaborations

Yoshiaki Okamiya has collaborated with notable colleagues such as Hisao Yamaguchi and Hideo Kanno. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Yoshiaki Okamiya's work exemplifies the impact of innovative research in the pharmaceutical industry. His patent for antihypertensive compounds highlights his commitment to improving health outcomes. Through his career at Teijin Limited and collaborations with esteemed colleagues, Okamiya continues to contribute to the advancement of medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…